Effect of finerenone on morbidity and mortality in chronic kidney disease and type 2 diabetes: FINE-HEART analysis of 3 randomized clinical trials
19 May 2025 (13:48 - 15:24)
Organised by: 
Abstract
Slides
About the speaker
Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)
4 More presentations in this session
Mrs V. Samsone (Vilnius, LT)
Doctor A. Gutowska (Gdansk, PL)
Doctor R. Fernandes (Coimbra, PT)
Doctor T. Pereira dos Santos (Coimbra, PT)
Access the full session
The Event
Heart Failure 2025
19 May 2025
13:48 CET
